<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Barrett's columnar epithelium with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is the most important risk factor for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the distal esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular mechanisms responsible for progression of columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> are mostly unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated expression of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene p53, E-cadherin expression and cell proliferation in the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In 24 patients with R0-resected <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> of the distal esophagus we evaluated the expression of E-cadherin (antibody HECD-1), mutated p53 (antibody DO1) and cell proliferation (antibody MiB1) by immunohistochemistry in sections of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, with and without <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and in squamous epithelium of the esophagus </plain></SENT>
<SENT sid="4" pm="."><plain>No p53 immunoreactivity was seen in sections of <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium or columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Fifty per cent of invasive <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> stained positive for mutated p53 </plain></SENT>
<SENT sid="6" pm="."><plain>The p53 expression correlated with the T-category (P = 0.048) and the N-category (P = 0.024) </plain></SENT>
<SENT sid="7" pm="."><plain>There was a significant decrease in the expression of E-cadherin from columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (P &lt; 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of E-cadherin in columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was similar to that seen in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium of the esophagus </plain></SENT>
<SENT sid="9" pm="."><plain>The Ki-67 proliferation fraction increased significantly from <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium to columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and to invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> (P &lt; 0.001), with a marked expansion of the proliferative component </plain></SENT>
<SENT sid="10" pm="."><plain>There was no correlation between cell proliferation, E-cadherin expression and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast to the alterations in the p53 expression, a decreased E-cadherin expression and the expansion of the proliferative component represent an early phenomenon in the malignant degeneration of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>This might aid in the early detection of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>